Endothelial dysfunction, vascular stiffness and their correction with perindopril, losartan in patients with ischemic heart disease, arterial hypertension and chronic kidney disease after coronary stenting

Objective. To study the state of arterial stiffness and endothelial function in patients with coronary heart disease (CHD), arterial hypertension (AH) in combination with chronic kidney disease (CKD) and to determine the effect of Perindopril and Losartan therapy on these indices including after coronary stenting. Materials and Methods. The study involved 73 patients with coronary heart disease (CHD), AH and CHD stage 2-3a. The comparison group consisted of 30 patients with CHD and AH without renal pathology. Patients with CKD were divided into 3 subgroups: the 1st - on conservative therapy with Perindopril 10 mg; the 2nd - with Losartan 100 mg daily; the 3rd - those who underwent coronary stenting and were treated with Perindopril 10 mg daily. Arterial stiffness, plasma levels of endothelin-1 (ET-1), metabolites of nitric oxide were assessed initially and after 12 weeks of therapy. Results. The patients with CHD and hypertension had a more severe endothelial dysfunction (ED) and more significant arterial stiffness. There was a correlation between GFR and PWV levels (r = -0.75; p = 0.001), nitric oxide levels (r = 0.58; p<0.01), ET-1 (r = -0.72; p < 0.01). After 12 weeks of therapy, all three subgroups showed a statistically significant decrease in ET-1 and vascular wall stiffness. Conclusion. Patients with CHD and AH, CKD had more profound ED and the severity of arterial stiffness. The use of Perindopril and Losartan in complex therapy resulted in a glomerular filtration rate increase, was accompanied by a corrective effect on ED and decreased arterial stiffness, especially in patients undergoing coronary stenting.

1. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. URL: https://apps.who.int/iris/handle/10665/332070.

2. Crews D.C., Bello A.K., Saadi G. Burden, access, and disparities in kidney disease. Nephrology (Saint-Petersburg). 2019;23(2):9-17 (in Russ.). DOI: 10.24884/1561-6274-2019-23-2-9-17. EDN: YZQRZB.

3. Tonelli M., Muntner P., Lloyd A., Manns B.J. Alberta Kidney Disease Network. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380(9844):807-814. DOI: 10.1016/S0140-6736(12)60572-8.

4. Kobalava Zh.D., Villevalde S.V., Batyushin M.М., Orlova G.М. The prevalence of chronic kidney disease markers in arterial hypertension patients and relation with diabetes: results of epidemiological study KHRONOGRAPH.Russian Journal of Cardiology. 2018;(2):91-101 (in Russ.). DOI: 10.15829/1560-4071-2018-2-91-101. EDN: YRGRAE.

5. Covic A., Haydar A.A., Bhamra-Ariza P., Gusbeth-Tatomir P., Goldsmith D.J. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol. 2005;18(4):388-396.

6. Safar M.E., Smulyan H. Coronary ischemic disease, arterial stiffness, and pulse pressure. Am J Hyper-tens. 2004;17(8):724-726. DOI: 10.1016/j.amjhyper.2004.06.004.

7. Mitchell G.F., Hwang S.J., Vasan R.S., Larson M.G., Pencina M.J., Hamburg N.M., Vita J.A., Levy D. et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505-511. DOI: 10.1161/CIRCULATIONAHA.109.886655.

8. Stam F., van Guldener C., Becker A., Dekker J.M., Heine R.J., Bouter L.M., Stehouwer C.D. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006;17(2):537-545. DOI: 10.1681/ASN.2005080834.

9. Tao J., Liu D.H., Wang L.C., Wang J.M., Wang Y., Yang Z., Lou Z.F., Tang A.L. Arterial elasticity identified by pulse wave analysis and its relation to endothelial function in patients with coronary artery disease. J Hum Hypertens. 2007;21(2):149-153. DOI: 10.1038/sj.jhh.1002112.

10. Cassese S., Byrne R.A., Schulz S., Hoppman P., Kreutzer J., Feuchtenberger A., Ibrahim T., Ott I. et al. Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting. Eur Heart J. 2015;36(2):94-99. DOI: 10.1093/eurheartj/ehu383.

11. Prskalo Z., Brizić I., Markota D., Markota I., Boban M., Tomic M., Starcevic B. Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:128. DOI: 10.1186/s12872-016-0305-4.

12. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111-1115. DOI: 10.1016/0140-6736(92)93147-f.

13. Ilyas B., Dhaun N., Markie D., Stansell P., Goddard J., Newby D.E., Webb D.J. Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM. 2009;102(3):183-191. DOI: 10.1093/qjmed/hcn171

14. Mattace-Raso F.U., van der Cammen T.J., Hofman A., van Popele N.M., Bos M.L., Schalekamp M.A., Asmar R., Reneman R.S. et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006 Feb 7;113(5):657-663. DOI: 10.1161/CIRCULATIONAHA.105.555235.

15. Silva I.V.G., de Figueiredo R.C., Rios D.R.A. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation.Int J Mol Sci. 2019;20(14):3458. DOI: 10.3390/ijms20143458.

16. Danilogorskaya Yu.A., Zheleznykh E.A., Privalova E.A., Belenkov Yu.N., Shchendrigina A.A., Kozhevnikova M.V., Shakaryants G.A., Zektser V.Yu. et al. Vasoprotective Effects of Prolonged Therapy With Perindopril A in Patients with Hypertension Including Concomitant Type 2 Diabetes Mellitus. Kardiologiia. 2020;60(1):4-9 (in Russ). DOI: 10.18087/cardio.2020.1.n888. EDN: MMAUBE.

17. Shahin Y., Khan J.A., Samuel N., Chetter I. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. Atherosclerosis. 2011;216(1):7-16. DOI: 10.1016/j.atherosclerosis.2011.02.044.

18. Ghiadoni L., Magagna A., Versari D., Kardasz I., Huang Y., Taddei S., Salvetti A. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003;41(6):1281-1286. DOI: 10.1161/01.HYP.0000070956.57418.22.

19. Anderson T.J., Elstein E., Haber H., Charbonneau F.Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000;35(1): 60-66. DOI: 10.1016/s0735-1097(99)00537-9.

20. Koh K.K., Han S.H., Chung W.J., Ahn J.Y., Jin D.K., Kim H.S., Park G.S., Kang W.C. et al.Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension. Am J Cardiol. 2004;93(11):1432-5, A10. DOI: 10.1016/j.amjcard.2004.02.050.

21. Panahova N.A. The role of inflammatory reactions and hemorheological indications in patients with restenosis after coronary angioplasty, optimization of treatment. Eurasian heart journal. 2018;(4):80-83 (in Russ.). EDN: YWJQMH.

22. Svarovskaya A.V., Teplyakov A.T., Gusakova A.M., Garganeeva A.A. Role of markers of inflammation and endothelial dysfunction in the prognosis of the development of cardiovascular complications in patients with coronary artery disease and metabolic syndrome after coronary stenting. Kardiologiia. 2020;60(8):98-105. (in Russ). DOI: 10.18087/cardio.2020.8.n966. EDN: JJQELB.

23. Trevelyan J., Needham E.W., Morris A., Mattu R.K.Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. Heart. 2005;91(8):1053-1057. DOI: 10.1136/hrt.2004.036897.

24. Prskalo Z., Brizić I., Markota D., Markota I., Boban M., Tomic M., Starcevic B. Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:128. DOI: 10.1186/s12872-016-0305-4.